Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2025-12-27 @ 10:11 AM
Study NCT ID:
NCT00303667
Status:
COMPLETED
Last Update Posted:
2017-12-28
First Post:
2006-03-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant
Sponsor:
Masonic Cancer Center, University of Minnesota
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2004LS042
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None